# Medefil Incorporated – FDA Inspection, Mar 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/medefil-incorporated/e62338a1-42a7-4a41-a48e-12108a4fc367
Source feed: FDA_Inspections

> FDA inspection 1046065 of Medefil Incorporated, March 29, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046065
- Company Name: Medefil Incorporated
- Inspection Date: 2018-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1251304 - 2025-04-21](https://www.keypedia.com/records/fda_inspections/medefil-incorporated/927e7b5d-5c6c-456c-a98c-ecb73375d64c)
- [FDA Inspection 1230282 - 2024-02-02](https://www.keypedia.com/records/fda_inspections/medefil-incorporated/475e69ff-287b-431d-816c-213239b5f140)
- [FDA Inspection 976257 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/medefil-incorporated/ebad0d59-2502-4ba6-9b4f-7af797b095bf)
- [FDA Inspection 894968 - 2014-09-15](https://www.keypedia.com/records/fda_inspections/medefil-incorporated/6fc698d5-41ce-4a0b-8541-c40f2ae4c445)
- [FDA Inspection 808935 - 2012-12-20](https://www.keypedia.com/records/fda_inspections/medefil-incorporated/8c97f00c-2a69-4874-ac11-17b4fcf6cb92)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-d-leach/2a3c4b73-f082-4f33-aa2d-52d1abbb6d55)

Company: https://www.keypedia.com/companies/medefil-incorporated/a2030c44-2817-4b9c-8416-f5af7691b9c5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c